Veralto Corporation's First Quarter 2026 Earnings Exceed Expectations
The first quarter of 2026 has been a strong start for Veralto Corporation, reflecting the effectiveness of its Enterprise System and the resilience of its end markets. According to Jennifer Honeycutt, President and Chief Executive Officer, the company delivered approximately 7% total sales growth and 13% adjusted earnings per share growth in Q1 2026.
In her opening remarks during the company's conference call on April 29th, Ms. Honeycutt highlighted that Veralto is off to a strong start in 2026, driven by the effectiveness of its Enterprise System and the essential role of its products and services in customers' operations. The company also continued to invest in commercial execution, productivity, and innovation.
Ms. Honeycutt noted that core sales growth is expected to accelerate as the year progresses, with the full-year adjusted earnings per share guidance raised to a range of $4.20-$4.28 per share. This increase reflects the company's momentum and strong first quarter performance.
In terms of strategic initiatives, Veralto has invested approximately $1 billion across two strategic acquisitions: In-Situ in its water quality segment and GlobalVision in its PQI segment. Additionally, the company initiated a new cost optimization program to streamline business operations and enhance operating efficiency.
Commenting on the upside in core sales growth, particularly within the water quality segment, Ms. Honeycutt attributed it to Veralto's higher bias or higher mix in OpEx versus CapEx. She highlighted that the company's products and services are integral to customer operations, where the cost of failure is high for them.
During the Q&A session, Deane Dray from RBC Capital Markets asked about the update on Trojan and quote activity within the CapEx side. Ms. Honeycutt responded that Veralto sees strong and stable demand across both its muni and industrial markets, with its products and services playing a crucial role in ensuring public safety, public health, and so on.
The company's balance sheet remains strong, providing flexibility to pursue additional acquisitions and share repurchases. Ms. Honeycutt expressed her pride in the team for a strong start to the year and for driving growth and continuous improvement as the year progresses and into next year.
